PACB Stock Summary and Trading Ideas (Pacific Biosciences Of California | NASDAQ:PACB)

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.

What symbol and exchange does Pacific Biosciences Of California shares trade?

Pacific Biosciences Of California trades on the NASDAQ stock market under the symbol PACB.

What is Pacific Biosciences Of California stock price doing today?

As of July 13, 2026, PACB stock price declined to $1.49 with 5,258,027 million shares trading.

What is Pacific Biosciences Of California's Beta?

PACB has a beta of 2.03, meaning it tends to be more sensitive to market movements. PACB has a correlation of 0.07 to the broad based SPY ETF.

How much is Pacific Biosciences Of California worth?

PACB has a market cap of $462.63 million. This is considered a Small Cap stock.

How much money does Pacific Biosciences Of California make?

Last quarter Pacific Biosciences Of California reported $37 million in Revenue and -$.12 earnings per share. This fell short of revenue expectation by $-3 million and exceeded earnings estimates by $.02.

What is the highest and lowest price Pacific Biosciences Of California traded in the last 3 year period?

In the last 3 years, PACB traded as high as $14.55 and as low as $.85.

What are the top ETFs holding Pacific Biosciences Of California?

The top ETF exchange traded funds that PACB belongs to (by Net Assets): ARKE, ARKK, ARKG, VTI, IWM.

Is Pacific Biosciences Of California (PACB) a good investment?

PACB has underperformed the market in the last year with a price return of +1.4% while the SPY ETF gained +21.3%. PACB has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +2.8% and -13.9%, respectively, while the SPY returned +9.5% and +1.1%, respectively.

What are the support and resistance levels for Pacific Biosciences Of California (PACB)?

PACB support price is $1.48 and resistance is $1.64 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PACB shares will trade within this expected range on the day.